|Systematic IUPAC name
N-Carbamimidoyl-N-methylglycine; Methylguanidoacetic acid
3D model (JSmol)
|Molar mass||131.135 g·mol−1|
|Melting point||255 °C (491 °F; 528 K)|
|13.3 g L−1 (at 18 ℃)|
Heat capacity (C)
|171.1 J K−1 mol−1 (at 23.2 ℃)|
|189.5 J K−1 mol−1|
Std enthalpy of
|−538.06–−536.30 kJ mol−1|
Std enthalpy of
|−2.3239–−2.3223 MJ mol−1|
|1=ATC code }}||C01EB06 (WHO)|
|GHS Signal word||WARNING|
|H315, H319, H335|
Related alkanoic acids
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|what is ?)(|
Creatine (// or //) is an organic compound with the nominal formula (H2N)(HN)CN(CH3)CH2CO2H. This species exists in various modifications (tautomers) in solution. Creatine is found in vertebrates where it facilitates recycling of adenosine triphosphate (ATP), the energy currency of the cell, primarily in muscle and brain tissue. Recycling is achieved by converting adenosine diphosphate (ADP) back to ATP via donation of phosphate groups. Creatine also acts as a buffer.
Creatine was first identified in 1832 when Michel Eugène Chevreul isolated it from the basified water-extract of skeletal muscle. He later named the crystallized precipitate after the Greek word for meat, κρέας (kreas). In 1928, creatine was shown to exist in equilibrium with creatinine. Studies in the 1920s showed that consumption of large amounts of creatine did not result in its excretion. This result pointed to the ability of the body to store creatine, which in turn suggested its use as a dietary supplement.
In 1912, Harvard University researchers Otto Folin and Willey Glover Denis found evidence that ingesting creatine can dramatically boost the creatine content of the muscle. In the late 1920s, after finding that the intramuscular stores of creatine can be increased by ingesting creatine in larger than normal amounts, scientists discovered creatine phosphate, and determined that creatine is a key player in the metabolism of skeletal muscle. The substance creatine is naturally formed in vertebrates.
The discovery of phosphocreatine was reported in 1927. In the 1960s, creatine kinase (CK) was shown to phosphorylate ADP using phosphocreatine (PCr) to generate ATP. It follows that ATP, not PCr is directly consumed in muscle contraction. CK uses creatine to "buffer" the ATP/ADP ratio.
While creatine's influence on physical performance has been well documented since the early twentieth century, it came into public view following the 1992 Olympics in Barcelona . An August 7, 1992 article in The Times reported that Linford Christie, the gold medal winner at 100 meters, had used creatine before the Olympics. An article in Bodybuilding Monthly named Sally Gunnell, who was the gold medalist in the 400-meter hurdles, as another creatine user. In addition, The Times also noted that 100 meter hurdler Colin Jackson began taking creatine before the Olympics.
thumb|left|Phosphocreatine relays phosphate to ADP. At the time, low-potency creatine supplements were available in Britain, but creatine supplements designed for strength enhancement were not commercially available until 1993 when a company called Experimental and Applied Sciences (EAS) introduced the compound to the sports nutrition market under the name Phosphagen. Research performed thereafter demonstrated that the consumption of high glycemic carbohydrates in conjunction with creatine increases creatine muscle stores.
left|thumb|The cyclic derivative creatinine exists in equilibrium with its tautomer and with creatine.
Creatine is a naturally occurring non-protein compound of which the primary metabolic role is to combine creatine with a phosphoryl group to generate phosphocreatine, which is used to regenerate ATP or Adenosine Triphosphate. Most of the human body's total creatine and phosphocreatine stores are found in skeletal muscle (95%), while the remainder is distributed in the blood, brain, testes, and other tissues. The average amount of total creatine (creatine and phosphocreatine) stored in the body is approximately 120 mmol/kg of dry muscle mass. However, the upper limit of creatine storage post supplementation and dietary intervention is believed to be around 160 mmol/kg. Studies have also shown that 1–2% of intramuscular creatine is degraded per day and an individual would need to consume about 1–3 grams of creatine per day to maintain average (unsupplemented) creatine storage. For most individuals about half (1 g/day) of this daily need is consumed from an omnivorous diet, while the remaining amount is synthesized in the liver and kidneys.
Creatine is not an essential nutrient. It is an amino acid derivative, naturally produced in the human body from the amino acids glycine and arginine, with an additional requirement for methionine to catalyze the transformation of guanidinoacetate to creatine. In the first step of the biosynthesis, the enzyme arginine:glycine amidinotransferase (AGAT, EC:18.104.22.168) mediates the reaction of glycine and arginine to form guanidinoacetate. This product is then methylated by guanidinoacetate N-methyltransferase (GAMT, EC:22.214.171.124), using S-adenosyl methionine as the methyl donor. Creatine itself can be phosphorylated by creatine kinase to form phosphocreatine, which is used as an energy buffer in skeletal muscles and the brain. A cyclic form of creatine, called creatinine, exists in equilibrium with its tautomer and with creatine.
Creatine is transported through the blood and taken up by tissues with high energy demands, such as the brain and skeletal muscle, through an active transport system. The concentration of ATP in skeletal muscle is usually 2–5 mM, which would result in a muscle contraction of only a few seconds. During times of increased energy demands, the phosphagen (or ATP/PCr) system rapidly resynthesizes ATP from ADP with the use of phosphocreatine (PCr) through a reversible reaction catalysed by the enzyme creatine kinase (CK). The phosphate group is attached to an NH center of the creatine. In skeletal muscle, PCr concentrations may reach 20–35 mM or more. Additionally, in most muscles, the ATP regeneration capacity of CK is very high and is therefore not a limiting factor. Although the cellular concentrations of ATP are small, changes are difficult to detect because ATP is continuously and efficiently replenished from the large pools of PCr and CK. A proposed representation has been illustrated by Krieder et al. Creatine has the ability to increase muscle stores of PCr, potentially increasing the muscle's ability to resynthesize ATP from ADP to meet increased energy demands.
Creatine supplementation appears to increase the number of myonuclei that satellite cells will 'donate' to damaged muscle fibers, which increases the potential for growth of those fibers. This increase in myonuclei probably stems from creatine's ability to increase levels of the myogenic transcription factor MRF4.
Genetic deficiencies in the creatine biosynthetic pathway lead to various severe neurological defects. Clinically, there are three distinct disorders of creatine metabolism. Deficiencies in the two synthesis enzymes can cause L-arginine:glycine amidinotransferase deficiency caused by variants in GATM and guanidinoacetate methyltransferase deficiency, caused by variants in GAMT. Both biosynthetic defects are inherited in an autosomal recessive manner. A third defect, creatine transporter defect, is caused by mutations in SLC6A8 and inherited in a X-linked manner. This condition is related to the transport of creatine into the brain.
Some studies suggest that total muscle creatine is significantly lower in vegetarians than non-vegetarians. This finding has been postulated to be due to an omnivorous diet being the primary source of creatine. Research shows that supplementation is needed to raise lacto-ovo vegetarian or vegan muscle creatine concentrations up to non-vegetarian levels.
Most of the research to-date on creatine has predominantly focused on the pharmacological properties of creatine, yet there is a lack of research into the pharmacokinetics of creatine. Studies have not established pharmacokinetic parameters for clinical usage of creatine such as volume of distribution, clearance, bioavailability, mean residence time, absorption rate, and half life. A clear pharmacokinetic profile would need to be established prior to optimal clinical dosing.
Taking creatine monohydrate in supplemental powder form showed that an initial loading dose of 5 grams of creatine taken four times a day in equally spaced intervals (total of 20 g/day) per day resulted in a rapid (20%) increase in total muscle creatine stores after 6 days. Alternatively, an approximation of 0.3 g/kg/day divided into 4 equal spaced intervals has also been suggested since creatine needs may vary based on body weight. It has also been shown that taking a lower dose of 3 grams a day for 28 days can also increase total muscle creatine storage to the same amount as the rapid loading dose of 20 g/day for 6 days. However, a 28 day loading phase does not allow for ergogenic benefits of creatine supplementation to be realized until fully saturated muscle storage.
This elevation in muscle creatine storage has been correlated with ergogenic benefits discussed in the therapeutic uses section. However, higher doses for longer periods of time are being studied to offset creatine synthesis deficiencies and mitigating diseases.
After the 5–7 day loading phase, muscle creatine stores are fully saturated and supplementation only needs to cover the amount of creatine broken down per day. This maintenance dose was originally reported to be around 2–3 g/day (or 0.03 g/kg/day), however, recent studies have suggested 3–5 g/day maintenance dose to maintain saturated muscle creatine.
Endogenous serum or plasma creatine concentrations in healthy adults are normally in a range of 2–12 mg/L. A single 5 gram (5000 mg) oral dose in healthy adults results in a peak plasma creatine level of approximately 120 mg/L at 1–2 hours post-ingestion. Creatine has a fairly short elimination half life, averaging just less than 3 hours, so to maintain an elevated plasma level it would be necessary to take small oral doses every 3–6 hours throughout the day.
Creatine as a performance enhancing supplement has received support from the Journal of the International Society of Sports Nutrition, and in joint position stands from the American College of Sports Medicine, Academy of Nutrition and Dietetics, and Dietitians in Canada.
Creatine use can increase maximum power and performance in high-intensity anaerobic repetitive work (periods of work and rest) by 5 to 15%. Creatine has no significant effect on aerobic endurance, though it will increase power during short sessions of high-intensity aerobic exercise.
A clinical study has shown that the intake of pure, high-quality creatine alone, or in combination with exercise, may reduce and delay age-related muscle atrophy, by improving fat-free body mass, muscle strength and endurance, while simultaneously improving bone density.
A meta-analysis found that creatine treatment increased muscle strength in muscular dystrophies, and potentially improved functional performance. Creatine treatment does not appear to improve muscle strength in people who have metabolic myopathies. High doses of creatine lead to increased muscle pain and an impairment in activities of daily living when taken by people who have McArdle disease.
According to a clinical study focusing on people with various muscular dystrophies, using a pure form of creatine monohydrate can be beneficial in rehabilitation after injuries and immobilization.
Creatine's impact on mitochondrial function has led to research on its efficacy and safety for slowing Parkinson's disease. As of 2014, the evidence did not provide a reliable foundation for treatment decisions, due to risk of bias, small sample sizes, and the short duration of trials.
- Weight gain due to extra water retention to the muscle
- Potential muscle cramps / strains / pulls
- Upset stomach
- High blood pressure due to extra water consumption
One well-documented effect of creatine supplementation is weight gain within the first week of the supplement schedule, likely attributable to greater water retention due to the increased muscle creatine concentrations.
A 2019 systematic review published by the National Kidney Foundation investigated whether creatine supplementation had adverse effects on renal function. They identified 15 studies from 1997–2013 that looked at standard creatine loading and maintenance protocols of 4–20 g/day of creatine versus placebo. They utilized serum creatinine, creatinine clearance, and serum urea levels as a measure of renal damage. While in general creatine supplementation resulted in slightly elevated creatinine levels that remained within normal limits, supplementation did not induce renal damage (P value< 0.001). Special populations included in the 2019 Systematic review included type 2 diabetic patients and post-menopausal women, bodybuilders, athletes, and resistance trained populations. The study also discussed 3 case studies where there were reports that creatine affected renal function.
In a joint statement between the American College of Sports Medicine, Academy of Nutrition and Dietetics, and Dietitians in Canada on performance enhancing nutrition strategies, creatine was included in their list of ergogenic aids and they do not list renal function as a concern for use.
The most recent position stand on creatine from the Journal of International Society of Sports Nutrition states that creatine is safe to take in healthy populations from infants to the elderly to performance athletes. They also state that long term (5 years) use of creatine has been considered safe.
It is important to mention that kidneys themselves, for normal physiological function, need phosphocreatine and creatine and indeed kidneys express significant amounts of creatine kinases (BB-CK and u-mtCK isoenzymes). At the same time, the first of two steps for endogenous creatine synthesis takes place in the kidneys themselves. Patients with kidney disease and those undergoing dialysis treatment generally show significantly lower levels of creatine in their organs, since the pathological kidneys are both hampered in creatine synthesis capability and are in back-resorption of creatine from the urine in the distal tubules. In addition, dialysis patients lose creatine due to wash out by the dialysis treatment itself and thus become chronically creatine depleted. This situation is exacerbated by the fact that dialysis patients generally consume less meat and fish, the alimentary sources of creatine. Therefore, to alleviate chronic creatine depletion in these patients and allow organs to replenish their stores of creatine, it was recently proposed to supplement dialysis patients with extra creatine, preferably by intra-dialytic administration. Such a supplementation with creatine in dialysis patients is expected to significantly improve the health and quality of the patients by improving muscle strength, coordination of movement, brain function and to alleviate depression and chronic fatigue that are common in these patients.
A 2011 survey of 33 supplements commercially available in Italy found that over 50% of them exceeded the European Food Safety Authority recommendations in at least one contaminant. The most prevalent of these contaminants was creatinine, a breakdown product of creatine also produced by the body. Creatinine was present in higher concentrations than the European Food Safety Authority recommendations in 44% of the samples. About 15% of the samples had detectable levels of dihydro-1,3,5-triazine or a high dicyandiamide concentration. Heavy metals contamination was not found to be a concern, with only minor levels of mercury being detectable. Two studies reviewed in 2007 found no impurities.
Creatine taken with medications that can harm the kidney can increase the risk of kidney damage:
- Nonsteroidal anti-inflammatory drugs (NSAIDs) – some examples are ibuprofen (Motrin, Advil) and naproxen (Aleve)
- Diuretics (water pills) – an example is furosemide (Lasix)
- Cimetidine (Tagamet)
A National Institutes of Health study suggests that caffeine interacts with creatine to increase the rate of progression of Parkinson's Disease.
Food and cooking
When creatine is mixed with protein and sugar at high temperatures (above 148 ℃), the resulting reaction produces carcinogenic heterocyclic amines (HCAs). Such a reaction happens when grilling or pan-frying meat. Creatine content (as a percentage of crude protein) can be used as an indicator of meat quality.
Creatine-monohydrate is suitable for vegetarians and vegans, as the raw materials used for the production of the supplement have no animal origin.
- Creatine methyl ester
- Essentials of Creatine in Sports and Health. Humana. 2008. ISBN 978-1-59745-573-2.
- "Creatine and the Liver: Metabolism and Possible Interactions". Mini Reviews in Medicinal Chemistry 16 (1): 12–8. 2016. doi:10.2174/1389557515666150722102613. PMID 26202197. "The process of creatine synthesis occurs in two steps, catalyzed by L-arginine:glycine amidinotransferase (AGAT) and guanidinoacetate N-methyltransferase (GAMT), which take place mainly in kidney and liver, respectively. This molecule plays an important energy/pH buffer function in tissues, and to guarantee the maintenance of its total body pool, the lost creatine must be replaced from diet or de novo synthesis.".
- "The creatine-creatinine equilibrium. The apparent dissociation constants of creatine and creatinine". The Biochemical Journal 22 (4): 920–9. 1928. doi:10.1042/bj0220920. PMID 16744118.
- Volek, Jeff S.; Ballard, Kevin D.; Forsythe, Cassandra E. (2008). "Overview of Creatine Metabolism". Essentials of Creatine in Sports and Health. Humana. pp. 1–23. ISBN 978-1-59745-573-2.
- Folin, Otto; Denis, W (1912). "Protein metabolism from the standpoint of blood and tissue analysis". Journal of Biological Chemistry 12 (1): 141–61. doi:10.1016/S0021-9258(18)88723-3. http://www.jbc.org/content/12/1/141.full.pdf+html.
- "The metabolic burden of creatine synthesis". Amino Acids 40 (5): 1325–31. May 2011. doi:10.1007/s00726-011-0853-y. PMID 21387089.
- Saks, Valdur (2007). Molecular system bioenergetics: energy for life. Weinheim: Wiley-VCH. p. 2. ISBN 978-3-527-31787-5. https://archive.org/details/molecularsystemb00saks.
- Ochoa, Severo (1989). Sherman, E. J.; National Academy of Sciences. eds. David Nachmansohn. Biographical Memoirs. 58. National Academies Press. pp. 357–404. ISBN 978-0-309-03938-3.
- "The Inorganic Phosphate and a Labile Form of Organic Phosphate in the Gastrocnemius of the Frog". The Biochemical Journal 21 (1): 190–5. 1927. doi:10.1042/bj0210190. PMID 16743804.
- "The nature of the 'inorganic phosphate' in voluntary muscle". Science 65 (1686): 401–3. April 1927. doi:10.1126/science.65.1686.401. PMID 17807679. Bibcode: 1927Sci....65..401F.
- "Introduction – Creatine: Cheap Ergogenic Supplement with Great Potential for Health and Disease". Creatine and Creatine Kinase in Health and Disease. Springer. 2007. pp. 1–16. ISBN 978-1-4020-6486-9. https://archive.org/details/creatinecreatine00salo.
- "Supplement muscles in on the market". National Review of Medicine. 2004-07-30. http://www.nationalreviewofmedicine.com/issue/2004_07_30/feature07_14.html.
- Passwater, Richard A. (2005). Creatine. p. 9. ISBN 978-0-87983-868-3. https://books.google.com/books?id=umy67wOLOckC. Retrieved 2011-05-25.
- Stoppani, Jim (May 2004). Creatine new and improved: recent high-tech advances have made creatine even more powerful. Here's how you can take full advantage of this super supplement. Muscle & Fitness. http://findarticles.com/p/articles/mi_m0801/is_5_65/ai_n6005938. Retrieved 2010-03-29.
- "Carbohydrate ingestion augments skeletal muscle creatine accumulation during creatine supplementation in humans". The American Journal of Physiology 271 (5 Pt 1): E821-6. November 1996. doi:10.1152/ajpendo.1996.271.5.E821. PMID 8944667.
- "Creatine supplementation with specific view to exercise/sports performance: an update". Journal of the International Society of Sports Nutrition 9 (1): 33. July 2012. doi:10.1186/1550-2783-9-33. PMID 22817979. "Creatine is produced endogenously at an amount of about 1 g/d. Synthesis predominately occurs in the liver, kidneys, and to a lesser extent in the pancreas. The remainder of the creatine available to the body is obtained through the diet at about 1 g/d for an omnivorous diet. 95% of the bodies creatine stores are found in the skeletal muscle and the remaining 5% is distributed in the brain, liver, kidney, and testes .".
- "The role of dietary creatine". Amino Acids 48 (8): 1785–91. August 2016. doi:10.1007/s00726-016-2188-1. PMID 26874700. "The daily requirement of a 70-kg male for creatine is about 2 g; up to half of this may be obtained from a typical omnivorous diet, with the remainder being synthesized in the body ... More than 90% of the body’s creatine and phosphocreatine is present in muscle (Brosnan and Brosnan 2007), with some of the remainder being found in the brain (Braissant et al. 2011). ... Creatine synthesized in liver must be secreted into the bloodstream by an unknown mechanism (Da Silva et al. 2014a)".
- "Muscle creatine loading in men". Journal of Applied Physiology 81 (1): 232–7. July 1996. doi:10.1152/jappl.19126.96.36.199. PMID 8828669.
- "Creatine in humans with special reference to creatine supplementation". Sports Medicine 18 (4): 268–80. October 1994. doi:10.2165/00007256-199418040-00005. PMID 7817065.
- "Elevation of creatine in resting and exercised muscle of normal subjects by creatine supplementation". Clinical Science 83 (3): 367–74. September 1992. doi:10.1042/cs0830367. PMID 1327657.
- "The metabolic burden of creatine synthesis". Amino Acids 40 (5): 1325–31. May 2011. doi:10.1007/s00726-011-0853-y. PMID 21387089. "Creatinine loss averages approximately 2 g (14.6 mmol) for 70 kg males in the 20- to 39-year age group. ... Table 1 Comparison of rates of creatine synthesis in young adults with dietary intakes of the three precursor amino acids and with the whole body transmethylation flux
Creatine synthesis (mmol/day) 8.3".
- "Creatine". Beth Israel Deaconess Medical Center. http://www.bidmc.org/YourHealth/ConditionsAZ.aspx?ChunkID=21706.
- "Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit' for cellular energy homeostasis". The Biochemical Journal 281 ( Pt 1) (Pt 1): 21–40. January 1992. doi:10.1042/bj2810021. PMID 1731757.
- "International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine". Journal of the International Society of Sports Nutrition 14: 18. 2017. doi:10.1186/s12970-017-0173-z. PMID 28615996.
- "The effects of creatine ethyl ester supplementation combined with heavy resistance training on body composition, muscle performance, and serum and muscle creatine levels". Journal of the International Society of Sports Nutrition 6 (1): 6. February 2009. doi:10.1186/1550-2783-6-6. PMID 19228401.
- "The creatine kinase system and pleiotropic effects of creatine". Amino Acids 40 (5): 1271–96. May 2011. doi:10.1007/s00726-011-0877-3. PMID 21448658. .
- T. Wallimann, M. Tokarska-Schlattner, D. Neumann u. a.: The Phosphocreatine Circuit: Molecular and Cellular Physiology of Creatine Kinases, Sensitivity to Free Radicals, and Enhancement by Creatine Supplementation. In: Molecular System Bioenergetics: Energy for Life. 22. November 2007. doi:10.1002/9783527621095.ch7C
- "Creatine supplementation: exploring the role of the creatine kinase/phosphocreatine system in human muscle". Canadian Journal of Applied Physiology 26 Suppl: S79-102. 2001. doi:10.1139/h2001-045. PMID 11897886.
- "L-Arginine:Glycine Amidinotransferase". https://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=602360.
- "Creatine deficiency syndromes and the importance of creatine synthesis in the brain". Amino Acids 40 (5): 1315–24. May 2011. doi:10.1007/s00726-011-0852-z. PMID 21390529. https://serval.unil.ch/resource/serval:BIB_CE3937F9A69E.P001/REF.pdf.
- "Effect of creatine and weight training on muscle creatine and performance in vegetarians". Medicine and Science in Sports and Exercise 35 (11): 1946–55. November 2003. doi:10.1249/01.MSS.0000093614.17517.79. PMID 14600563.
- "The influence of creatine supplementation on the cognitive functioning of vegetarians and omnivores". The British Journal of Nutrition 105 (7): 1100–5. April 2011. doi:10.1017/S0007114510004733. PMID 21118604.
- "Clinical pharmacology of the dietary supplement creatine monohydrate". Pharmacological Reviews 53 (2): 161–76. June 2001. PMID 11356982.
- "Protein- and carbohydrate-induced augmentation of whole body creatine retention in humans". Journal of Applied Physiology 89 (3): 1165–71. September 2000. doi:10.1152/jappl.2000.89.3.1165. PMID 10956365.
- "Creatine synthesis and exchanges between brain cells: What can be learned from human creatine deficiencies and various experimental models?". Amino Acids 48 (8): 1877–95. August 2016. doi:10.1007/s00726-016-2189-0. PMID 26861125.
- "Creatine for neuroprotection in neurodegenerative disease: end of story?". Amino Acids 48 (8): 1929–40. August 2016. doi:10.1007/s00726-015-2165-0. PMID 26748651.
- "Effects of creatine supplementation on performance and training adaptations". Molecular and Cellular Biochemistry 244 (1–2): 89–94. February 2003. doi:10.1023/A:1022465203458. PMID 12701815.
- "Influence of oral creatine supplementation of muscle torque during repeated bouts of maximal voluntary exercise in man". Clinical Science 84 (5): 565–71. May 1993. doi:10.1042/cs0840565. PMID 8504634.
- "Comparison of new forms of creatine in raising plasma creatine levels". Journal of the International Society of Sports Nutrition 4: 17. November 2007. doi:10.1186/1550-2783-4-17. PMID 17997838.
- "Long-term creatine intake is beneficial to muscle performance during resistance training". Journal of Applied Physiology 83 (6): 2055–63. December 1997. doi:10.1152/jappl.19188.8.131.525. PMID 9390981. http://jap.physiology.org/cgi/pmidlookup?view=long&pmid=9390981.
- "Creatine supplementation with specific view to exercise/sports performance: an update". Journal of the International Society of Sports Nutrition 9 (1): 33. July 2012. doi:10.1186/1550-2783-9-33. PMID 22817979.
- "ISSN exercise & sports nutrition review update: research & recommendations". Journal of the International Society of Sports Nutrition 15 (1): 38. August 2018. doi:10.1186/s12970-018-0242-y. PMID 30068354.
- "American College of Sports Medicine position stand. Nutrition and athletic performance". Medicine and Science in Sports and Exercise 41 (3): 709–31. March 2009. doi:10.1249/MSS.0b013e31890eb86. PMID 19225360.
- "Creatine supplementation and exercise performance: recent findings". Sports Medicine 35 (2): 107–25. 2005. doi:10.2165/00007256-200535020-00002. PMID 15707376.
- "Creatine supplementation and exercise performance: a brief review". Journal of Sports Science & Medicine 2 (4): 123–32. December 2003. PMID 24688272.
- "Creatine Supplementation and Lower Limb Strength Performance: A Systematic Review and Meta-Analyses". Sports Medicine 45 (9): 1285–1294. September 2015. doi:10.1007/s40279-015-0337-4. PMID 25946994.
- "Creatine supplementation in endurance sports". Medicine and Science in Sports and Exercise 30 (7): 1123–9. July 1998. doi:10.1097/00005768-199807000-00016. PMID 9662683.
- "Creatine: a review of efficacy and safety". Journal of the American Pharmaceutical Association 39 (6): 803–10; quiz 875–7. 1999. doi:10.1016/s1086-5802(15)30371-5. PMID 10609446.
- "Office of Dietary Supplements - Dietary Supplements for Exercise and Athletic Performance" (in en). https://ods.od.nih.gov/factsheets/ExerciseAndAthleticPerformance-HealthProfessional/#creatine.
- "Cognitive effects of creatine ethyl ester supplementation". Behavioural Pharmacology 20 (8): 673–9. December 2009. doi:10.1097/FBP.0b013e3283323c2a. PMID 19773644. http://jtoomim.org/files/Ling_2009-Cognitive_effects_of_creatine_ethyl_ester_supplementation.pdf.
- "Creatine – Nootropics Expert". https://nootropicsexpert.com/creatine/.
- "8 Reasons Creatine is the Best Nootropic Source Right Now". 30 October 2018. https://www.paleofx.com/nootropics-creatine/.
- Wallimann, Theo (2014). "Positive Wirkung von Kreatin im Alter und für Rehabilitation.". Schweizer Zeitschrift für Ernährungsmedizin (2): 31–33. ISSN 1660-4695. https://www.rosenfluh.ch/media/ernaehrungsmedizin/2014/01/Lesermeinung__Positive_Wirkung_von_Kreatin_im_Alter_und_fur_die_Rehabilitation.pdf.
- "Creatine for treating muscle disorders". The Cochrane Database of Systematic Reviews (6): CD004760. June 2013. doi:10.1002/14651858.CD004760.pub4. PMID 23740606.
- "Creatine monohydrate in muscular dystrophies: A double-blind, placebo-controlled clinical study". Neurology 54 (9): 1848–50. May 2000. doi:10.1212/wnl.54.9.1848. PMID 10802796.
- "Creatine for Parkinson's disease". The Cochrane Database of Systematic Reviews (6): CD009646. June 2014. doi:10.1002/14651858.cd009646.pub2. PMID 24934384.
- "Creatine supplementation in Huntington's disease: a placebo-controlled pilot trial". Neurology 61 (7): 925–30. October 2003. doi:10.1212/01.wnl.0000090629.40891.4b. PMID 14557561.
- "Creatine supplementation lowers brain glutamate levels in Huntington's disease". Journal of Neurology 252 (1): 36–41. January 2005. doi:10.1007/s00415-005-0595-4. PMID 15672208.
- "The CREST-E study of creatine for Huntington disease: A randomized controlled trial". Neurology 89 (6): 594–601. August 2017. doi:10.1212/WNL.0000000000004209. PMID 28701493.
- "Creatine for amyotrophic lateral sclerosis/motor neuron disease". The Cochrane Database of Systematic Reviews 12: CD005225. December 2012. doi:10.1002/14651858.CD005225.pub3. PMID 23235621.
- "Side effects of creatine supplementation in athletes". International Journal of Sports Physiology and Performance 1 (4): 311–23. December 2006. doi:10.1123/ijspp.1.4.311. PMID 19124889.
- "International Society of Sports Nutrition position stand: creatine supplementation and exercise". Journal of the International Society of Sports Nutrition (jissn) 4: 6. August 2007. doi:10.1186/1550-2783-4-6. PMID 17908288.
- "International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine". Journal of the International Society of Sports Nutrition 14: 18. 2017-06-13. doi:10.1186/s12970-017-0173-z. PMID 28615996.
- "Does creatine supplementation hinder exercise heat tolerance or hydration status? A systematic review with meta-analyses". Journal of Athletic Training 44 (2): 215–23. 2009. doi:10.4085/1062-6050-44.2.215. PMID 19295968.
- "Putting to rest the myth of creatine supplementation leading to muscle cramps and dehydration". British Journal of Sports Medicine 42 (7): 567–73. July 2008. doi:10.1136/bjsm.2007.042473. PMID 18184753.
- "Effects of Creatine Supplementation on Renal Function: A Systematic Review and Meta-Analysis". Journal of Renal Nutrition 29 (6): 480–489. November 2019. doi:10.1053/j.jrn.2019.05.004. PMID 31375416.
- "Creatine supplementation does not impair kidney function in type 2 diabetic patients: a randomized, double-blind, placebo-controlled, clinical trial". European Journal of Applied Physiology 111 (5): 749–56. May 2011. doi:10.1007/s00421-010-1676-3. PMID 20976468.
- "Effect of creatine supplementation on measured glomerular filtration rate in postmenopausal women". Applied Physiology, Nutrition, and Metabolism 36 (3): 419–22. June 2011. doi:10.1139/h11-014. PMID 21574777.
- "Does long-term creatine supplementation impair kidney function in resistance-trained individuals consuming a high-protein diet?". Journal of the International Society of Sports Nutrition 10 (1): 26. May 2013. doi:10.1186/1550-2783-10-26. PMID 23680457.
- "Long-term creatine supplementation does not significantly affect clinical markers of health in athletes". Molecular and Cellular Biochemistry 244 (1–2): 95–104. February 2003. doi:10.1023/A:1022469320296. PMID 12701816.
- "Creatine supplementation does not affect clinical health markers in football players". British Journal of Sports Medicine 42 (9): 731–5. September 2008. doi:10.1136/bjsm.2007.030700. PMID 18780799.
- "Creatine supplementation associated with resistance training does not alter renal and hepatic functions" (in en). Revista Brasileira de Medicina do Esporte 17 (4): 237–241. August 2011. doi:10.1590/S1517-86922011000400004. ISSN 1517-8692.
- "Effects of long-term creatine supplementation on liver and kidney functions in American college football players". International Journal of Sport Nutrition and Exercise Metabolism 12 (4): 453–60. December 2002. doi:10.1123/ijsnem.12.4.453. PMID 12500988.
- "Acute renal failure in a young weight lifter taking multiple food supplements, including creatine monohydrate". Journal of Renal Nutrition 16 (4): 341–5. October 2006. doi:10.1053/j.jrn.2006.04.025. PMID 17046619.
- "The effects of the recommended dose of creatine monohydrate on kidney function". NDT Plus 4 (1): 23–4. February 2011. doi:10.1093/ndtplus/sfq177. PMID 25984094.
- "Effects of oral creatine supplementation in a patient with MELAS phenotype and associated nephropathy". Neuropediatrics 33 (3): 157–61. June 2002. doi:10.1055/s-2002-33679. PMID 12200746.
- ML.Guerrero, J.Beron, B.Spindler, P.Grosscurth, T.Wallimann and F.Verrey.Metabolic support of Na+ pump in apically permeabilized A6 kidney cell epithelia: role of creatine kinase.In: Am J Physiol. 1997 Feb;272(2 Pt 1):C697-706. doi:10.1152/ajpcell.1997.272.2.C697, PMID 9124314
- T. Wallimann, U. Riek, M. M. Möddel: Intradialytic creatine supplementation: A scientific rationale for improving the health and quality of life of dialysis patients.In: Medical Hypotheses 2017 Febr;99, S. 1-14. doi:10.1016/j.mehy.2016.12.002, PMID 28110688.
- "Levels of creatine, organic contaminants and heavy metals in creatine dietary supplements". Food Chemistry 126 (3): 1232–1238. June 2011. doi:10.1016/j.foodchem.2010.12.028.
- "Safety of creatine supplementation". Creatine and Creatine Kinase in Health and Disease. Subcellular Biochemistry. 46. 2007. pp. 275–89. doi:10.1007/978-1-4020-6486-9_14. ISBN 978-1-4020-6485-2.
- "Creatine". Natural Medicines Comprehensive Database Consumer Version. http://www.webmd.com/vitamins-supplements/ingredientmono-873-creatine.aspx?activeingredientid=873&activeingredientname=creatine.
- "Caffeine and Progression of Parkinson Disease: A Deleterious Interaction With Creatine". Clinical Neuropharmacology 38 (5): 163–9. 2015. doi:10.1097/WNF.0000000000000102. PMID 26366971.
- "Heterocyclic Amines in Cooked Meats". National Cancer Institute. 15 Sep 2004. http://www.cancer.gov/cancertopics/factsheet/Risk/heterocyclic-amines.
- "Chemicals in Meat Cooked at High Temperatures and Cancer Risk". National Cancer Institute. 2 April 2018. http://www.cancer.gov/cancertopics/factsheet/Risk/cooked-meats.
- Dahl, Olle (1 July 1963). "Meat Quality Measurement, Creatine Content as an Index of Quality of Meat Products". Journal of Agricultural and Food Chemistry 11 (4): 350–355. doi:10.1021/jf60128a026.
- Gießing, Jürgen (20 February 2019). Kreatin: Eine natürliche Substanz und ihre Bedeutung für Muskelaufbau, Fitness und Anti-Aging. pp. 135–136, 207. ISBN 9783752803969. https://books.google.com/books?id=_xxgDwAAQBAJ&lpg=PP4.
Original source: https://en.wikipedia.org/wiki/ Creatine. Read more